Cutting the pill burden: new study aims to simplify meds for kidney patients in qatar

NCT ID NCT06324045

First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 29 times

Summary

This study tests a team-based program to safely reduce or stop unnecessary medications in people with chronic kidney disease. Researchers will enroll 424 patients in Qatar to see if the program lowers the number of risky drugs, reduces daily pill count, and improves quality of life. The goal is to make medication management safer and less burdensome for kidney patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hamad Medical Corporation

    RECRUITING

    Doha, 3050, Qatar

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.